drugset / Trial / NCT06491394

Lactoferrin Effect on Kidney and Heart of Rhabdomyolysis Rats

NCT06491394

Phase 4 Completed 24 enrolled Aswan University Hospital
RandomizedParallel-groupTriple-blindPrevention

Summary

This study focuses on detecting the possible beneficial effect of Lactoferrin (Lf) administration on the kidney and the heart of glycerol-induced rhabdomyolysis (RM) in rats and its relation to ferroptosis and AMPK/Nrf2/ HO-1 signalling pathway. The main questions it aims to answer are: 1. Is Lf administration 30 min. before or after RM induction in rats beneficial to kidneys and heart? 2. When administered to glycerol-induced rats, does Lf act by upregulating the AMPK/Nrf2/ HO-1 signalling pathway and inhibiting ferroptosis?

Timeline

Start
2024-11-01
Primary completion
2025-03-01
Completion
2025-04-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lactoferrin Protein / enzyme biologic 1000 mg/kg Oral
Comparator Glycerin Other / unclassified 10 ml Intramuscular

Indications